the diagnostic, prognostic and follow-up value of serum bcl-2, bax and p53 proteins in breast cancer patients: a comparison with serum ca 15-3
نویسندگان
چکیده
background : biomarkers accepted for clinical use in breast cancer have low sensitivity and specificity. thus, there is a need for new markers to assist in the diagnosis, prognosis and follow-up of breast cancer patients. this study aims to investigate the diagnostic, prognostic and follow-up role of serum bcl-2, bax and p53 proteins in breast cancer patients in comparison with those of serum ca 15-3 as the most commonly used breast cancer marker. methods : we analyzed 50 breast cancer patients (before surgery, after one month of surgery and after six cycles of chemotherapy) and 50 normal healthy controls for serum bcl-2, bax, p53 and ca 15-3 levels. results : mean serum bcl-2 and ca 15-3 levels significantly increased, whereas the mean serum p53 level significantly declined in breast cancer patients compared to normal healthy controls. using the roc curve analysis, serum p53 had the greatest area under the curve (85.6%). serum bcl-2 levels significantly decreased after six cycles of chemotherapy compared with its level one month after surgery. preoperative serum levels of bcl-2, bax, p53 and ca 15-3 were non-significantly correlated with patient's disease-free survival. conclusion : serum p53 was superior to bcl-2 and ca 15-3 in the diagnosis of breast cancer patients. only bcl-2 could be used for monitoring the effect of chemotherapy on breast cancer patients. none of the assayed biomarkers had a role in monitoring the effect of surgery on breast cancer patients. none of the assayed biomarkers had a prognostic role for breast cancer patients.
منابع مشابه
Comparison Between Serum Soluble Fas, P53 and Serum Ca 15-3 in Breast Cancer Patients
Serum sFas and p53 protein have been observed in breast cancer patients, but their clinical usefulness for diagnosis and therapy monitoring has not been clarified. This study was carried out to compare the clinical utility of serum sFas and p53 protein with that of serum CA 15-3 as the most commonly used breast cancer tumor marker. In this study, serum samples were taken from 35 normal healthy ...
متن کاملDiagnostic value of measuring serum CA 15-3, TPA, and TPS in women with breast cancer.
INVESTIGATION The concentrations of CA 15-3, TPA, and TPS were determined in the serum of 90 women with breast cancer MATERIAL/METHODS Serum CA 15-3 levels were determined by Abbott immunofluorescent tests, TPA concentration using the Byk-Roland immunoluminometric method, and TPS by the BEKI Diagnostics immunoenzymatic method. RESULTS In the diagnosis of breast cancer, the TPA test had the ...
متن کاملSerum Level of HER-2 Extracellular Domain in Iranian Patients with Breast Cancer: A Follow-up Study
Background: A soluble form of HER-2/neu extracellular domain (sHER-2) is reported to be released in the sera of metastatic breast cancer patients. Objective: To measure the level of sHER-2 in sera of 115 breast cancer patients. Methods: Serial samples of 27 patients with metastasis, 18 non-metastatic patients, 15 patients in stage 0/I and 14 patients with accompanying benign breast disease were...
متن کاملthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
BACKGROUND Serum HER-2/neu antigen concentrations have been reported to correlate with increased tumor volume in patients with breast cancer. We measured serum CA 15-3, a surrogate marker of disease burden, and correlated serum CA 15-3 with serum HER-2/neu and analyzed the association of both markers with clinical outcomes. METHODS Pretreatment serum samples from 566 patients were retrospecti...
متن کاملClinical Value of Serum S100A8/A9 and CA15-3 in the Diagnosis of Breast Cancer
Background and Objective: S100A8/A9 is a heterodimer calcium-binding protein which is involved in tumor cell proliferation, adhesion and invasion, and is proposed as a biomarker for better diagnosis and prognosis in many cancers. The aim of this study was to evaluate the simultaneous serum-based level of S100A8/A9 and CA15-3 as well-illustrated cancer biomarkers, as well as the...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
middle east journal of cancerجلد ۴، شماره ۲، صفحات ۵۱-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023